| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.957 | 27 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.2305 | 23 |
| GSM780709 | Untreated after 4 days (C3_1) | 39.4778 | 5 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.1105 | 42 |
| GSM780720 | Untreated after 4 days (C2_2) | 38.0609 | 3 |
| GSM780721 | Untreated after 4 days (C3_2) | 39.4281 | 5 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 35.333 | 1 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 35.886 | 1 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.6554 | 25 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 36.3168 | 1 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 40.5819 | 8 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 42.9903 | 17 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 38.2796 | 3 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.165 | 42 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.2389 | 23 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.1799 | 14 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.5832 | 43 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.0403 | 10 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.1997 | 7 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 38.148 | 3 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.826 | 21 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.9765 | 22 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 42.6727 | 16 |